Clinical Trial Update: BS01 in Patients With Retinitis Pigmentosa [Phase 1, Phase 2]

View source ↗

Summary

BS01 is being studied in a Phase 1/2 clinical trial for Retinitis Pigmentosa and is currently recruiting. The sponsor and developer is Bionic Sight LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• BS01

Snippet

Sponsor: Bionic Sight LLC | Conditions: Retinitis Pigmentosa | Phase 1, Phase 2 | Status: RECRUITING